Advertisement

Advertisement

CLNN Stock Latest News

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Novel Multiple Sclerosis Therapy Toward Phase 2 Trials

TipRanks NewswireQuantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Novel Multiple Sclerosis Therapy Toward Phase 2 Trials

Clene Extends Note Maturities and Expands Equity Plan

PremiumCompany Announcements

Clene Extends Note Maturities and Expands Equity Plan

2M ago

Roth says FDA approving Clene’s ALS treatment NDA a ‘long shot’

PremiumThe Fly

Roth says FDA approving Clene’s ALS treatment NDA a ‘long shot’

2M ago

Analyst Reiterates Buy on Advancing CNM-Au8 ALS Pathway and Funding Visibility; $31 Price Target Maintained

PremiumRatings

Analyst Reiterates Buy on Advancing CNM-Au8 ALS Pathway and Funding Visibility; $31 Price Target Maintained

2M ago

Clene reports Q1 EPS (69c), consensus (70c)

PremiumThe Fly

Clene reports Q1 EPS (69c), consensus (70c)

2M ago

Clene Extends Debt Maturities and Strengthens Cash Runway

PremiumCompany AnnouncementsClene Extends Debt Maturities and Strengthens Cash Runway

2M ago

CLNN Earnings this Week: How Will it Perform?

Pre-Earnings

CLNN Earnings this Week: How Will it Perform?

2M ago

Clene price target raised to $50 from $48 at Canaccord

The Fly

Clene price target raised to $50 from $48 at Canaccord

2M ago

Clene Announces $7 Million Registered Direct Equity Offering

PremiumCompany Announcements

Clene Announces $7 Million Registered Direct Equity Offering

2M ago

Clene provides update on NDA for ALS following Type C meeting with FDA

PremiumThe Fly

Clene provides update on NDA for ALS following Type C meeting with FDA

2M ago

Clene Advances CNM-Au8 Toward Accelerated ALS Approval

PremiumCompany Announcements

Clene Advances CNM-Au8 Toward Accelerated ALS Approval

2M ago

Clene, Lovesac, HDFC Bank, State Street, Vor Shock

PremiumWeekend Updates

Clene, Lovesac, HDFC Bank, State Street, Vor Shock

3M ago

Surf Air, Cytokinetics, ASE, Itau, Clene Insider Shake-Up

PremiumWeekend UpdatesSurf Air, Cytokinetics, ASE, Itau, Clene Insider Shake-Up

3M ago

Insiders Cash Out: Cytokinetics, Itau, ASE, Clene, Black Stone

Weekend Updates

Insiders Cash Out: Cytokinetics, Itau, ASE, Clene, Black Stone

3M ago

Clene Secures Third-Year NIH Subaward for ALS Program

Company Announcements

Clene Secures Third-Year NIH Subaward for ALS Program

4M ago

Clene reports FY25 EPS ($2.65), consensus ($2.35)

PremiumThe Fly

Clene reports FY25 EPS ($2.65), consensus ($2.35)

4M ago

Clene outlines 2026 regulatory milestones and ALS strategy

PremiumCompany Announcements

Clene outlines 2026 regulatory milestones and ALS strategy

5M ago

Clene issues letter to shareholders on CNM-Au8 2026 catalysts

PremiumThe Fly

Clene issues letter to shareholders on CNM-Au8 2026 catalysts

5M ago

Madrigal, Clene, Cencora, Sequans, Amicus: Insider Moves Exposed

PremiumWeekend Updates

Madrigal, Clene, Cencora, Sequans, Amicus: Insider Moves Exposed

6M ago

Clene Announces Multi-Tranche Financing to Extend Cash Runway

PremiumCompany AnnouncementsClene Announces Multi-Tranche Financing to Extend Cash Runway

6M ago

Clene Advances CNM-Au8 ALS Program with FDA Meeting

Company Announcements

Clene Advances CNM-Au8 ALS Program with FDA Meeting

6M ago

Clene announces additional CNM-Au8 biomarker data for potential NDA filing

The Fly

Clene announces additional CNM-Au8 biomarker data for potential NDA filing

6M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >